Results of Annual General Meeting 10th April 2008

11/04/2008

Evolutec Group plc
(“Evolutec” or “the Company”)

Evolutec Group plc. Results of Annual General Meeting 10 April 2008

Results of Annual General Meeting 10th April 2008 (PDF)

Evolutec is pleased to announce that all the resolutions proposed at its Annual General Meeting held today, 10 April 2008, were passed.

Evolutec will continue to seek an investment in a single, profitable UK or European un-quoted company with an established trading record in the areas of technology, healthcare or the service sector. It is anticipated that the investment would be an active investment and will constitute a reverse takeover.

The four directors of Evolutec have considerable expertise in mergers, acquisitions, the sale of businesses and the valuation of investments in the aforementioned sectors. It is expected that the directors, working with appropriate advisers including Numis Securities (the Company’s Nomad), will undertake the due diligence for any proposed investment.

Under AIM Rule 15 the Company will continue as an investment company for 12 months during which time it is required to undertake a reverse takeover or otherwise implement its investment strategy. Should the Company fail to undertake either of the above, the Board anticipates that the shares will be suspended on 13 April 2009 or the Company will notify the market of any change.

Enquiries:

Dr David P Bloxham, Chairman 07771 525 875
Mr Michael Meade, Numis Securities 0207 260 1000
Mr Oliver Cardigan, Numis Securities 0207 260 1000

Safe Harbour Statement

This news release may contain forward-looking statements that reflect the current expectations of the Company regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors including the success of the Company's strategy, the successful integration of completed mergers and acquisitions and achievement of expected synergies from such transactions, and the ability of the Company to identify and consummate suitable strategic and business combination transactions.